Outcomes of Antituberculous Therapy in Patients Undergoing Decortication for Tuberculous Empyema and Its Association with Duration of Antituberculous Therapy
DOI:
https://doi.org/10.54112/bcsrj.v6i8.2225Keywords:
Tuberculosis; Empyema, Pleural; Antitubercular Agents; Thoracic Surgery; Postoperative ComplicationsAbstract
Empyema is a severe pleural complication of tuberculosis that often requires surgical decortication when organized pleural disease leads to trapped lung and impaired respiratory mechanics. Although antituberculous therapy (ATT) is the cornerstone of treatment, the optimal duration of preoperative ATT before decortication remains uncertain, particularly in high-burden countries such as Pakistan. This study evaluated postoperative outcomes of decortication in relation to the duration of preoperative ATT. Objective: To determine the outcomes of antituberculous therapy in patients undergoing decortication for tuberculous empyema and to assess the association between postoperative outcomes and the duration of preoperative ATT. Methods: This descriptive case series was conducted in the Department of Thoracic Surgery, Gulab Devi Teaching Hospital, Lahore, from 19 December 2024 to 19 June 2025. A total of 80 adult patients with tuberculous empyema undergoing decortication were enrolled through consecutive non-probability sampling. Patients were divided into two equal groups based on the duration of preoperative ATT: Group A received ATT for more than 6 weeks, while Group B received ATT for less than 6 weeks. Outcomes assessed on the seventh postoperative day included air leak, mechanical ventilator requirement, intensive care unit (ICU) admission, and residual pleural collection. Data were analyzed using SPSS version 29, with p≤0.05 considered statistically significant. Results: The mean age of the patients was 39.8±13.4 years, and 65.0% were male. Postoperative complications were significantly more frequent in patients receiving ATT for less than 6 weeks. Air leak occurred in 17.5% of Group A versus 40.0% of Group B (p=0.026), mechanical ventilator requirement in 7.5% versus 25.0% (p=0.032), ICU admission in 10.0% versus 30.0% (p=0.024), and residual collection in 12.5% versus 35.0% (p=0.018). Overall, at least one complication was recorded in 47.5% of Group A compared with 77.5% of Group B (p=0.006). Conclusion: A preoperative ATT duration of more than 6 weeks was associated with significantly better early postoperative outcomes after decortication for tuberculous empyema. Optimizing ATT duration before surgery may reduce postoperative morbidity and improve recovery in patients with tuberculous empyema.
Downloads
References
1. Goletti D, Meintjes G, Andrade BB, Zumla A, Lee SS. Insights from the 2024 WHO Global Tuberculosis Report—more comprehensive action, innovation, and investments required for achieving the WHO End TB goals. Int J Infect Dis. 2025;150:107325. DOI: https://doi.org/10.1016/j.ijid.2024.107325
2. Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P, et al. Global Tuberculosis Report 2020—reflections on the global TB burden, treatment and prevention efforts. Int J Infect Dis. 2021;113 Suppl 1:S7-S12. DOI: https://doi.org/10.1016/j.ijid.2021.02.107
3. Schwalb A, Samad Z, Yaqoob A, Fatima R, Houben RMGJ. Subnational tuberculosis burden estimation for Pakistan. PLoS Glob Public Health. 2024;4(9):e0003653. DOI: https://doi.org/10.1371/journal.pgph.0003653
4. Khan PY, Paracha MS, Grundy C, Madhani F, Saeed S, Maniar L, et al. Insights into tuberculosis burden in Karachi, Pakistan: a concurrent adult tuberculosis prevalence and child Mycobacterium tuberculosis infection survey. PLoS Glob Public Health. 2024;4(8):e0002155. DOI: https://doi.org/10.1371/journal.pgph.0002155
5. Shaw JA, Diacon AH, Koegelenberg CFN. Tuberculous pleural effusion. Respirology. 2019;24(10):962-971. DOI: https://doi.org/10.1111/resp.13673
6. Lo Cascio CM, Kaul V, Dhooria S, Agrawal A, Chaddha U. Diagnosis of tuberculous pleural effusions: a review. Respir Med. 2021;188:106607. DOI: https://doi.org/10.1016/j.rmed.2021.106607
7. Abraham SV, Chikkahonnaiah P. Change in pulmonary function following decortication for chronic pleural empyema. Turk Thorac J. 2020;21(1):27-31. DOI: https://doi.org/10.5152/TurkThoracJ.2019.180146
8. Sikander N, Ahmad T, Mazcuri M, Ali N, Thapaliya P, Nasreen S, et al. Role of anti-tuberculous treatment in the outcome of decortication for chronic tuberculous empyema. Cureus. 2021;13(1):e12583. DOI: https://doi.org/10.7759/cureus.12583
9. Yao L, Wang B, Chen X, Liu Q, Sheng J, Liu X, et al. The safety and efficacy of decortication for stage III drug-resistant tuberculous empyema. Interdiscip Cardiovasc Thorac Surg. 2023;37(5):ivad166. DOI: https://doi.org/10.1093/icvts/ivad166
10. Majeed FA, Zafar U, Chatha SS, Ali A, Raza A. Decortication as an option for empyema thoracis. J Coll Physicians Surg Pak. 2020;30(3):313-317. DOI: https://doi.org/10.29271/jcpsp.2020.03.313
11. Liu X, Wang X, Sheng J, Jiang Y, Li L, Dai X. Open decortication for patients presenting with stage III tuberculous empyema with low-density lines on CT imaging. Sci Rep. 2023;13(1):9658. DOI: https://doi.org/10.1038/s41598-023-36420-w
12. Liu J, Luan Y, Han Q, Zhao W. Measures to accelerate recovery from stage III tuberculous empyema: tuberculous empyema surgical and recovery methods. Perioper Med (Lond). 2025;14(1):43. DOI: https://doi.org/10.1186/s13741-025-00530-y
13. Pulle MV, Tiwari N, Asaf BB, Puri HV, Bishnoi S, Gopinath SK, et al. Does an enhanced recovery after surgery protocol affect perioperative surgical outcomes in stage III tubercular empyema? A comparative analysis of 243 patients. Asian Cardiovasc Thorac Ann. 2021;29(2):105-110. DOI: https://doi.org/10.1177/0218492320966435
14. Alioke II, Anumenechi N, Edaigbini SA. Treatment outcomes of tuberculous and non-tuberculous empyema thoracis. J West Afr Coll Surg. 2020;10(1):15-19. DOI: https://doi.org/10.4103/jwas.jwas_43_21
15. Lin CM, Chen YL, Cheng YF, Cheng CY, Huang CL, Hung WH, et al. Clinical characteristics and decortication outcomes of bacterial, tuberculous, and fungal pleural infection. Int J Tuberc Lung Dis. 2024;28(11):541-546. DOI: https://doi.org/10.5588/ijtld.24.0146
16. Liu CC, Chen YL, Cheng CY, Huang CL, Hung WH, Wang BY. Risk factors and prognostic predictors of recurrent bacterial empyema in patients after surgical treatment. BMC Infect Dis. 2025;25(1):667. DOI: https://doi.org/10.1186/s12879-025-11077-0
17. Sakai T, Sano A, Azuma Y, Koezuka S, Otsuka H, Shimizu H, et al. Preoperative undernutrition predicts postoperative complications of acute empyema. Health Sci Rep. 2021;4(1):e232. DOI: https://doi.org/10.1002/hsr2.232
18. Sun W, Yin G, Cai H, Zhou Y, Gu J, Chen S, et al. The efficacy and safety of uniportal video-assisted thoracic surgery on the treatment of stage II-III tuberculous empyema: a single-arm clinical retrospective study from 2016 to 2021 in a thoracic surgery center in China. BMC Pulm Med. 2022;22(1):398. DOI: https://doi.org/10.1186/s12890-022-02182-w
19. Zhou Y, Li X, Dai J, Lin L, Cao X, Liu X, et al. Uniportal thoracoscopic decortication for stage III tuberculous empyema with severe rib crowding. Ann Thorac Surg. 2021;112(1):289-294. DOI: https://doi.org/10.1016/j.athoracsur.2020.07.067
20. Kumar A, Lingaraju CV, Pulle MV, Asaf BB, Puri HV, Bishnoi S. Comparison of outcome of surgery for tubercular and nontubercular empyema: an analysis of 285 consecutive cases. Lung India. 2021;38(6):514-519. DOI: https://doi.org/10.4103/lungindia.lungindia_33_21
21. Shirakawa C, Shiroshita A, Kimura Y, Anan K, Cong Y, Tomii K, et al. Prognostic factors for discharge directly home in patients with thoracoscopic surgery for empyema: a multicenter retrospective cohort study. Surg Infect (Larchmt). 2024;25(2):147-154. DOI: https://doi.org/10.1089/sur.2023.193
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Muhammad Toqeer Zahid, Muhammad Nabeel Farooq, Ali Raza Khan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
